摘要
目的:探讨妊娠糖尿病(GDM)患者血浆纤溶酶原激活物抑制剂-1(PAI-1)与胰岛素抵抗(IR)的关系。方法:选择31例妊娠糖尿病患者(GDM组)和35例糖耐量正常孕妇(NC组)作对照,分别测定PAI-1、空腹血糖(FPG)、空腹胰岛素(FIns)和糖化血红蛋白(HbAlc)水平,同时计算胰岛素抵抗指数(HOMA-IR)和胰岛β细胞功能指数(HOMA-HBCl),分析比较两组的差异与关系。结果:①GDM组的PAI-1、HOMA-IR、HOMA-HBCI分别为(60.84±27.81)ng/L、0.53±0.18、2.22±0.19;NC组分别为(36.85±11.61)ng/L、0.27±0.13、2.41±0.16,两组比较差异有统计学意义(P<0.01)。②相关性分析:血浆PAI-1分别与HOMA-IR、空腹胰岛素(FIns)、孕前BMI正相关,相关系数分别为:r=0.525,P=0.001;r=0.550,P=0.001;r=0.625,P=0.000。③多元逐步回归分析发现血浆PAI-1与HOMA-IR具有高度相关性。结论:GDM患者的血浆PAI-1水平明显升高与IR密切相关,PAI-1与GDM的发病有关。
Objective:To explore the correlation between Plasminogen activator inhibitor-l(PAI-l)and insulin resistance(IR) in patients with gestational diabetes mellitus(GDM).Methods:The levels of PAI-I,FPG,Fins,HbA1c from 31 patients with GDM(GDM group) and 35 pregnant women with normal glucose tolerance(NC group) were detected.Homeostasis model insulin resistance index(HOMA-IR) was applied to assess the status of IR Insulin secretion by the homeostasis β-cell function index(HOMA-HBCI).The difference in HOMA-IR,HOMA-HBCI,PAI-land other biochemistry indexes between the two groups were compared and analyzed.Results:①The levels of PAI-1,HOMA-IR and HOMA-HBCI were(60.84±27.81) ng/L,(0.53± 0.18),(2.22±0.19) in GDM group and(36.85±11.61) ng/L,(0.27±0.13),(2.41±0.16) in NC group,there was significant difference between two groups(P〈0.01).②The level of PAI-1 was correlated with HOMA-IR(r=0.525,P=0.001) Fins(r=0.550,P=0.001),BMI(r=0.625,P=0.000).③A multiple linear stepwise regression analysis indicated that HOMA-IR was the important effect factors of PAI-1.Conclusion:The level of PAI-1 increase in women with GDM,which is related to IR and may participate in the pathogenesis of GDM.
出处
《中国妇幼保健》
CAS
北大核心
2010年第25期3541-3543,共3页
Maternal and Child Health Care of China
基金
温州市卫生局课题基金资助项目〔2008002〕